GLP-1 Agonists: Supporting Success with Nutrition and Lifestyle Considerations (1 hour) CE/CME Course #: 25-397 This course reviews clinical evidence for glucagon-like peptide-1 (GLP-1) receptor agonists for conditions including type 2 diabetes and weight loss
Histologically, Sections of the left testes in group 2 showed irregularities in germinal epithelial cell configuration and degeneration in several cells, and all the samples of the right testes in group 2 had arrested sperm maturation and primary spermatocytes had a dusky appearance in some tubules, while all remaining groups were normal
Limited Research Though peptides have considerable promise, research is still in progress
The reduced caloric intake contributes to this
Abstract Glucagon-like peptide-1 (GLP-1) was initially considered to be a hormone with a predominant role in regulating glucose metabolism by inducing insulin secretion, reducing glucagon secretion, and ameliorating insulin resistance, with the last effect being largely dependent on the induction of weight loss
What to Do if Prescribed Off-Label Uses: Review Insurance Policy: Carefully examine your insurance policy to understand coverage details and any restrictions related to medications